Christian Ottmann
Founder & Chief Executive Officer Ambagon Therapeutics
Christian Ottmann, Ph.D., is Associate Professor for Molecular Cell and Structural Biology at Eindhoven University of Technology, The Netherlands. He has focused on 14-3-3 structural and chemical biology since beginning his Ph.D. research. He has been involved in several early drug discovery projects with the pharmaceutical industry and was coordinator of the FP7 Industry-Academia Partnership and Pathways (IAPP) 14-3-3STABS. Before taking up his current position in Eindhoven, he was a group leader at the Chemical Genomics Centre (CGC) of the Max Planck Society in Dortmund, Germany, headed by Herbert Waldmann. He obtained his Ph.D. (summa cum laude) in 2003 from the University of Tübingen with Claudia Oecking. In 2012 he was recipient of the Innovation Award in Medicinal/Pharmaceutical Chemistry of the DCh/DPhG and in 2013 of the Young Chemical Biologist Award of the International Chemical Biology Society (ICBS).
Seminars
- Leveraging structural biology and computational modelling to systematically design and optimize molecular glue therapeutics.
- Unlocking novel disease pathways by targeting proteins previously considered inaccessible to conventional drug discovery approaches.
- Advancing a next-generation pipeline of molecular glue candidates through datadriven discovery and preclinical validation.
